Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

SEATTLE, March 11, 2024 -- Perspective Therapeutics, Inc. , a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that...

Related Keywords

United States ,American ,Michaelk Schultz ,Thijs Spoor ,Markus Puhlman ,Henryn Wagner Jr ,Richardl Wahl ,Exchange Commission ,American College Of Radiology ,National Academy Of Medicine ,York Stock Exchange On ,American Association Of Physicians ,Washington University School Of Medicine ,American Society For Clinical Investigation ,Perspective Therapeutics Inc ,Washington University In St ,Department Of Energy ,Mallinckrodt Institute Of Radiology ,Society Of Nuclear Medicine ,New York Stock Exchange ,Chief Executive ,Chief Science ,Chief Medical ,Mallinckrodt Institute ,Washington University School ,Nuclear Medicine ,Johns Hopkins University ,Charles De Hevesy Award ,Molecular Imaging ,American Society ,Clinical Investigation ,American Association ,National Academy ,American College ,Washington University ,Perspective Therapeutics ,Transition Report ,Quarterly Report ,Markets ,